Evaluation of Safety and Efficacy of the FlexStent® Femoropopliteal Self-Expanding Stent System

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 257 participants.

Also called NCT01355406

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 257 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01355406
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States, Belgium (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01355406. Allocation not applicable; no masking; primary purpose treatment. Start 2011-09-16 (actual); primary completion 2016-01-15 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluation of Safety and Efficacy of the FlexStent® Femoropopliteal Self-Expanding Stent System
Acronym
OPEN
Condition
Peripheral Artery Disease
Condition
Peripheral Vascular Disease
Condition
Vascular Disease
Condition
Cardiovascular Diseases
Condition
PAD
Intervention (Device)
FlexStent® Femoropopliteal Self Expanding Stent System
Lead sponsor
Cordis US Corp. (class: industry)
Collaborator
Massachusetts General Hospital (class: other)
Collaborator
Prairie Education and Research Cooperative (class: industry)

Record details

Record id
cardio:ct-nct01355406
Content hash
1f70552f6e9a1f4f21d7ed11505e2eca2b50336df74f360f717f6937bde11b14